Yue-Yang Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yue-Yang Liu has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- David Wei Zhang
State Key Lab of ASIC & Systems, Fudan University, Shanghai 201203, China
7 shared publications - Wei Zhou
Department of Chemistry, Fudan University, 2205 Songhu Road, Shanghai 200438, China
7 shared publications - Zhan-Ting Li
State Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, 200032, China
7 shared publications - Shang-Bo Yu
State Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, University of Chinese Academy of Sciences, 345 Lingling Lu, Shanghai 200032, China
5 shared publications Hui Wang
Department of Chemistry, Fudan University, 2205 Songhu Road, Shanghai 200438, China
4 shared publications- Da Ma
School of Pharmaceutical and Chemical Engineering & Institute for Advanced Studies, Taizhou University, 1139 Shifu Avenue, Taizhou 318000, Zhejiang, China
3 shared publications
Latest Publications
- 24 January 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (7) , 7031-7043
Discovery of an Ultralong-acting Nondepolarizing Neuromuscular Blocker That Displays Short Onset Time and On-Demand Rapid Reversal by a Biocompatible Antagonist
The combination of ultralong-acting neuromuscular block and subsequent on-demand rapid reversal may provide prolonged surgeries with improved conditions by omitting continuous or repetitive blocker administration, enabling a more stable and predictable hemodynamic profile and eliminating residual block. For this target, we prepared 19 imidazolium-incorporated tetracationic macrocycles. In vivo studies with rats revealed that one macrocycle (IMC-14) displays extremely high blocking activity. At the dose of 12.5-fold ED90, IMC-14 exhibits an onset time shorter than that of cisatracurium of 2-fold dose and a duration time corresponding to more than 13 h for human adults. Moreover, within the dose range of 12.5-187.5-fold ED90, the profound block induced by IMC-14 can be rapidly reversed at any stage by a highly biocompatible acyclic cucurbit[n]uril antagonist, with a reversal time significantly shorter than that achieved by sugammadex for reversing the block of rocuronium, a clinically widely used intermediate-acting neuromuscular blocking agent.
- 24 January 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (7) , 7031-7043
Discovery of an Ultralong-acting Nondepolarizing Neuromuscular Blocker That Displays Short Onset Time and On-Demand Rapid Reversal by a Biocompatible Antagonist
The combination of ultralong-acting neuromuscular block and subsequent on-demand rapid reversal may provide prolonged surgeries with improved conditions by omitting continuous or repetitive blocker administration, enabling a more stable and predictable hemodynamic profile and eliminating residual block. For this target, we prepared 19 imidazolium-incorporated tetracationic macrocycles. In vivo studies with rats revealed that one macrocycle (IMC-14) displays extremely high blocking activity. At the dose of 12.5-fold ED90, IMC-14 exhibits an onset time shorter than that of cisatracurium of 2-fold dose and a duration time corresponding to more than 13 h for human adults. Moreover, within the dose range of 12.5-187.5-fold ED90, the profound block induced by IMC-14 can be rapidly reversed at any stage by a highly biocompatible acyclic cucurbit[n]uril antagonist, with a reversal time significantly shorter than that achieved by sugammadex for reversing the block of rocuronium, a clinically widely used intermediate-acting neuromuscular blocking agent.
- 10 December 2024
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 8 (1) , 792-802
Supramolecular Organic Framework that Enables Multifunctional Doxorubicin Delivery, Photofrin Post-treatment Phototoxicity Inhibition, and Heparin Neutralization
Although porous frameworks are structurally ideal for the development of biomaterials through drug adsorption, sequestration, and delivery, integration of multiple biofunctions into a biocompatible porous framework would greatly improve its potential for preclinical investigations by increasing both therapeutic value and research and development efficiency. Herein, we report the preparation of a highly biocompatible supramolecular organic framework from an imidazolium-derived tetrahedral monomer and cucurbit[8]uril. The supramolecular organic framework has been revealed to have regular intrinsic porosity and adsorb doxorubicin, photofrin, and heparins driven by hydrophobicity and/or ion-pairing electrostatic interactions. In vivo or in vitro assays illustrate that this adsorption leads to efficient intracellular delivery of doxorubicin, which enhances its antitumor efficacy, elimination of photofrin, which inhibits its post-treatment phototoxicity without reducing its photodynamic therapeutic activity, and sequestration of (low-molecular-weight) heparins, which neutralizes their anticoagulation activity more efficiently than clinically used protamine.
- 10 December 2024
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 8 (1) , 792-802
Supramolecular Organic Framework that Enables Multifunctional Doxorubicin Delivery, Photofrin Post-treatment Phototoxicity Inhibition, and Heparin Neutralization
Although porous frameworks are structurally ideal for the development of biomaterials through drug adsorption, sequestration, and delivery, integration of multiple biofunctions into a biocompatible porous framework would greatly improve its potential for preclinical investigations by increasing both therapeutic value and research and development efficiency. Herein, we report the preparation of a highly biocompatible supramolecular organic framework from an imidazolium-derived tetrahedral monomer and cucurbit[8]uril. The supramolecular organic framework has been revealed to have regular intrinsic porosity and adsorb doxorubicin, photofrin, and heparins driven by hydrophobicity and/or ion-pairing electrostatic interactions. In vivo or in vitro assays illustrate that this adsorption leads to efficient intracellular delivery of doxorubicin, which enhances its antitumor efficacy, elimination of photofrin, which inhibits its post-treatment phototoxicity without reducing its photodynamic therapeutic activity, and sequestration of (low-molecular-weight) heparins, which neutralizes their anticoagulation activity more efficiently than clinically used protamine.
- 26 September 2024
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 67 (19) , 17905-17918
Structure–Activity Relationship Studies Leading to the Discovery of Highly Water-Soluble and Biocompatible Acyclic Cucurbit[n]uril FY-3451 as a Universal Antagonist That Rapidly Reverses Neuromuscular Blocking Agents In Vivo
The development of a reversal agent that can rapidly reverse clinically used nondepolarizing neuromuscular blocking agents (NMBAs) has long been a challenge. Here, we report the synthesis of a series of highly water-soluble acyclic cucurbit[n]urils (acCBs). Systematic structure-activity relationship studies reveal that introducing two propylidene units on the peripheral benzene rings not only remarkably improves the activity of the corresponding derivative acCB6 (FY 3451) in reversing the neuromuscular block of rocuronium, cisatracurium, vecuronium, and pancuronium, the four clinically used NMBAs, through stable inclusion, but also allows for high water-solubility as well as a maximum tolerated dose (2000 mg/kg on rats). In vivo experiments with rats show that, at the identical dose of 25 mg/kg, for rocuronium, vecuronium, and pancuronium, acCB6 can achieve a recovery time shorter than that of sugammadex for rocuronium and, at the dose of 100 mg/kg, realize comparably rapid reversal for cisatracurium.
- 26 September 2024
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 67 (19) , 17905-17918
Structure–Activity Relationship Studies Leading to the Discovery of Highly Water-Soluble and Biocompatible Acyclic Cucurbit[n]uril FY-3451 as a Universal Antagonist That Rapidly Reverses Neuromuscular Blocking Agents In Vivo
The development of a reversal agent that can rapidly reverse clinically used nondepolarizing neuromuscular blocking agents (NMBAs) has long been a challenge. Here, we report the synthesis of a series of highly water-soluble acyclic cucurbit[n]urils (acCBs). Systematic structure-activity relationship studies reveal that introducing two propylidene units on the peripheral benzene rings not only remarkably improves the activity of the corresponding derivative acCB6 (FY 3451) in reversing the neuromuscular block of rocuronium, cisatracurium, vecuronium, and pancuronium, the four clinically used NMBAs, through stable inclusion, but also allows for high water-solubility as well as a maximum tolerated dose (2000 mg/kg on rats). In vivo experiments with rats show that, at the identical dose of 25 mg/kg, for rocuronium, vecuronium, and pancuronium, acCB6 can achieve a recovery time shorter than that of sugammadex for rocuronium and, at the dose of 100 mg/kg, realize comparably rapid reversal for cisatracurium.
- Open Access
- 26 June 2024
- Published by OAE Publishing Inc. in Chemical Synthesis
- Vol. 4 (2)
Synthesis and intracellular basic protein delivery of a polyanionic flexible organic framework
Although cationic porous polymers have been widely used for gene and drug delivery, the delivering function of anionic porous polymers has rarely been explored. Herein, we prepare a polyanionic flexible organic framework (pa-FOF) through the quantitative formation of the acylhydrazone bond from a tetraanionic tetraaldehyde and a tetraanionic diacylhydrazine. Pa-FOF is highly water-soluble and has a size of 26 to 51 nm, which depends on the concentration of the monomers, and an aperture of approximately 3.8 nm. Fluorescence, zeta potential, confocal laser scanning microscopic and flow cytometric experiments reveal that pa-FOF can adsorb basic proteins, including lysozyme, trypsin and cytochrome c, which is driven by intermolecular ion-pairing electrostatic attraction and hydrophobicity, and realizes efficient intracellular delivery of the adsorbed proteins. Confocal laser scanning microscopic imaging experiments further illustrate that the delivery of cytochrome c can significantly increase its ability of causing cell apoptosis.
- 26 June 2024
- Published by OAE Publishing Inc. in Chemical Synthesis
- Vol. 4 (2)
Open AccessSynthesis and intracellular basic protein delivery of a polyanionic flexible organic framework
Although cationic porous polymers have been widely used for gene and drug delivery, the delivering function of anionic porous polymers has rarely been explored. Herein, we prepare a polyanionic flexible organic framework (pa-FOF) through the quantitative formation of the acylhydrazone bond from a tetraanionic tetraaldehyde and a tetraanionic diacylhydrazine. Pa-FOF is highly water-soluble and has a size of 26 to 51 nm, which depends on the concentration of the monomers, and an aperture of approximately 3.8 nm. Fluorescence, zeta potential, confocal laser scanning microscopic and flow cytometric experiments reveal that pa-FOF can adsorb basic proteins, including lysozyme, trypsin and cytochrome c, which is driven by intermolecular ion-pairing electrostatic attraction and hydrophobicity, and realizes efficient intracellular delivery of the adsorbed proteins. Confocal laser scanning microscopic imaging experiments further illustrate that the delivery of cytochrome c can significantly increase its ability of causing cell apoptosis.
- 9 April 2024
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 11 (11) , 3019-3025
Assembly of ionic supramolecular polymers using a decacationic pillar[5]arene to noncovalently crosslink hyaluronic acid for short DNA delivery
Three ionic supramolecular polymers (ISPs) have been assembled from an imidazolium-modified decacationic pillar[5]arene (P5A) and hyaluronic acid (HA, MW = 3000 Da) by controlling their molar ratio at 1 : 0.2, 1 : 0.4 or 1 : 0.6. Dynamic light scattering experiments show that at [P5A] = 16 μM the ISPs afford nano-scale aggregates with hydrodynamic diameters of 21, 33 and 21 nm, respectively. Fluorescence and zeta potential experiments support that the ISPs include short single- and double-stranded DNA of 21 nucleotides. Fluorescence imaging and flow cytometric analysis demonstrate that the ISPs can deliver the included DNA into both normal and cancer cells, with the percentage of delivered cells reaching up to 99.7%. In vitro and in vivo assays reveal that the second ISP has the highest biocompatibility, and mixing with HA improves the biocompatibility of P5A.
- 9 April 2024
- Published by Royal Society of Chemistry (RSC) in Organic Chemistry Frontiers
- Vol. 11 (11) , 3019-3025
Assembly of ionic supramolecular polymers using a decacationic pillar[5]arene to noncovalently crosslink hyaluronic acid for short DNA delivery
Three ionic supramolecular polymers (ISPs) have been assembled from an imidazolium-modified decacationic pillar[5]arene (P5A) and hyaluronic acid (HA, MW = 3000 Da) by controlling their molar ratio at 1 : 0.2, 1 : 0.4 or 1 : 0.6. Dynamic light scattering experiments show that at [P5A] = 16 μM the ISPs afford nano-scale aggregates with hydrodynamic diameters of 21, 33 and 21 nm, respectively. Fluorescence and zeta potential experiments support that the ISPs include short single- and double-stranded DNA of 21 nucleotides. Fluorescence imaging and flow cytometric analysis demonstrate that the ISPs can deliver the included DNA into both normal and cancer cells, with the percentage of delivered cells reaching up to 99.7%. In vitro and in vivo assays reveal that the second ISP has the highest biocompatibility, and mixing with HA improves the biocompatibility of P5A.
- Open Access
- 20 July 2022
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 13 (32) , 9243-9248
Flexible organic frameworks sequester neuromuscular blocking agents in vitro and reverse neuromuscular block in vivo
Water-soluble flexible organic frameworks are prepared and used to sequester neuromuscular blocking agents, and reverse their neuromuscular block in vivo.
- 20 July 2022
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 13 (32) , 9243-9248
Open AccessFlexible organic frameworks sequester neuromuscular blocking agents in vitro and reverse neuromuscular block in vivo
Water-soluble flexible organic frameworks are prepared and used to sequester neuromuscular blocking agents, and reverse their neuromuscular block in vivo.
- 27 April 2022
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 10 (22) , 4163-4171
Conjugating aldoxorubicin to supramolecular organic frameworks: polymeric prodrugs with enhanced therapeutic efficacy and safety
Supramolecular organic frameworks have been utilized to conjugate aldoxorubicin to give polymeric prodrugs, which achieves enhanced anti-tumour activity through the delivery of the frameworks.
- 27 April 2022
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 10 (22) , 4163-4171
Conjugating aldoxorubicin to supramolecular organic frameworks: polymeric prodrugs with enhanced therapeutic efficacy and safety
Supramolecular organic frameworks have been utilized to conjugate aldoxorubicin to give polymeric prodrugs, which achieves enhanced anti-tumour activity through the delivery of the frameworks.